Literature DB >> 9804153

Retinal vasculature changes in Norrie disease mice.

M Richter1, J Gottanka, C A May, U Welge-Lüssen, W Berger, E Lütjen-Drecoll.   

Abstract

PURPOSE: To correlate morphologic changes in the retinal vasculature with degenerative changes in the neuronal retina of mice lacking 56 amino acids from the N-terminus of the Norrie disease (ND) gene product.
METHODS: Posterior eye segments of ND mice of different age groups were investigated by light and electron microscopy (EM) and scanning EM of vascular corrosion cast preparations. The results were qualitatively and quantitatively compared with those obtained in age-matched littermate control mice and C57B1/6 mice.
RESULTS: Quantitative evaluation revealed an increase in the number of blood vessels in the interface of the ganglion cell layer and the nerve fiber layer and a decrease in the inner and outer plexiform layers in ND mice older than 9 days compared with control mice. Vessels were also seen adjacent to the vitreous surface of the inner limiting membrane. Most of these vessels showed fenestrations and occasionally penetrated the inner limiting membrane. Hyaloid vessels were still present in the vitreous. The abnormal vascularization pattern was found in the entire retina and occurred in addition to the previously described alterations of the neuronal retina.
CONCLUSIONS: There is a malformation of the retinal vasculature and a persistence of hyaloid vessels in the vitreous of ND mice. It is assumed that the ND gene product is required for normal vascularization of the inner retinal layers and for atrophy of hyaloid vessels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804153

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  37 in total

1.  Ophthalmology in the post-genomic era.

Authors:  G C Black; M E Boulton; P N Bishop; D McLeod
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

3.  Norrie disease and peripheral venous insufficiency.

Authors:  M Michaelides; P J Luthert; R Cooling; H Firth; A T Moore
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 4.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

5.  Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain.

Authors:  Xin Ye; Philip Smallwood; Jeremy Nathans
Journal:  Gene Expr Patterns       Date:  2010-11-03       Impact factor: 1.224

6.  Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.

Authors:  Minrong Ai; Shauna Heeger; Cynthia F Bartels; Deborah K Schelling
Journal:  Am J Hum Genet       Date:  2005-09-27       Impact factor: 11.025

Review 7.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

8.  Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.

Authors:  Xin Ye; Yanshu Wang; Hugh Cahill; Minzhong Yu; Tudor C Badea; Philip M Smallwood; Neal S Peachey; Jeremy Nathans
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

9.  Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.

Authors:  Yanshu Wang; Amir Rattner; Yulian Zhou; John Williams; Philip M Smallwood; Jeremy Nathans
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

10.  A nonautonomous role for retinal frizzled-5 in regulating hyaloid vitreous vasculature development.

Authors:  Jianmin Zhang; Sabine Fuhrmann; Monica L Vetter
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.